CWG
XLRN

C WorldWide Group’s Acceleron Pharma XLRN Stock Holding History

C WorldWide Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,146
Closed -$224K – 126
2018
Q4 		$224K Sell
5,146
-132
-3% -$6.59K ﹤0.01% 118
2018
Q3 		$302K Buy
5,278
+741
+16% +$36.4K ﹤0.01% 122
2018
Q2 		$220K Hold
4,537
– – ﹤0.01% 122
2018
Q1 		$177K Sell
4,537
-125
-3% -$5.31K ﹤0.01% 120
2017
Q4 		$198K Sell
4,662
-714
-13% -$26.8K ﹤0.01% 118
2017
Q3 		$201K Buy
5,376
+837
+18% +$29.1K ﹤0.01% 123
2017
Q2 		$138K Sell
4,539
-358
-7% -$10.4K ﹤0.01% 127
2017
Q1 		$130K Sell
4,897
-423
-8% -$11.1K ﹤0.01% 126
2016
Q4 		$136K Sell
5,320
-11,080
-68% -$351K ﹤0.01% 121
2016
Q3 		$594K Hold
16,400
– – 0.01% 118
2016
Q2 		$557K Hold
16,400
– – 0.01% 107
2016
Q1 		$433K Hold
16,400
– – 0.01% 114
2015
Q4 		$800K Sell
16,400
-1,460
-8% -$52.5K 0.01% 118
2015
Q3 		$445K Buy
17,860
+360
+2% +$10.8K 0.01% 126
2015
Q2 		$554K Buy
17,500
+7,000
+67% +$226K 0.01% 124
2015
Q1 		$400K Hold
10,500
– – 0.01% 103
2014
Q4 		$409K Hold
10,500
– – 0.01% 96
2014
Q3 		$312K Buy
+10,500
New +$296K ﹤0.01% 99

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

C WorldWide Group's XLRN Position: Q1 2019 in Review

C WorldWide Group sold out of Acceleron Pharma (XLRN) in Q1 2019, closing a stake of 5,146 shares — an estimated $224K sold.

C WorldWide Group first reported a position in XLRN in Q3 2014 and held it in 18 quarters. The position peaked at $800K in Q4 2015. 171 funds tracked by Wall St. Rank hold XLRN as of Q1 2019.

  • C WorldWide Group reported no remaining Acceleron Pharma position as of Q1 2019 after selling out during the quarter.
  • C WorldWide Group sold 5,146 Acceleron Pharma shares in Q1 2019, an estimated $224K.
  • C WorldWide Group first reported a position in Acceleron Pharma in Q3 2014 and held it in 18 quarters.
  • C WorldWide Group's Acceleron Pharma position peaked at $800K in Q4 2015.
  • 171 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2019.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.